Navigation Links
Breast Cancer Numbers Dip Most in Wealthy, Urban Areas
Date:6/26/2009

Hormone-replacement therapy probably accounts for differences between rich and poor women: study

FRIDAY, June 26 (HealthDay News) -- Cases of invasive breast cancer in the United States have declined overall, but the decrease is significantly less marked in poor women who live in rural areas, possibly due to differences in the use of hormone therapy (HT), a new study suggests.

Researchers at the Northern California Cancer Center studied national breast cancer incidence data for the years 1997 to 2004 to compare rates in rural and urban areas and poor and rich areas of the country.

"Between 2001 and 2004, incidence rates of invasive breast cancer declined more than 8 percent in the United States," study leader Christina Clarke said in a news release. "One possible explanation for this is widespread discontinuation of and/or failure to initiate HT. Because this cessation of HT use was more pronounced in rich/urban areas, we wanted to see if there was a corresponding difference in breast cancer incidence between these areas and poor/rural parts of the country."

She and her colleagues found that overall invasive breast cancer incidence declined 13.2 percent, with notable differences between urban (-13.8 percent) and rural (-7.5 percent) women, and those in counties with high (-9.6 percent), middle (-13.8 percent) and low (-13 percent) poverty rates.

The researchers noted that breast cancer incidence rates in rural counties peaked in 1999 and then declined steadily, while rates in urban counties fell dramatically after 2002. This difference may be because of variations in levels of exposure to news linking hormone therapy with breast cancer. The fact that women in urban areas had more exposure to media reports about the HT/breast cancer relationship likely contributed to a larger decrease in hormone therapy among those women.

"Understanding what specific populations were involved in breast cancer declines helps us to better plan prevention efforts for the future, especially with the aging of the baby boomer population into prime breast cancer age," Clarke said.

The study appears in the journal BMC Medicine.

More information

The U.S. National Cancer Institute has more about hormone therapy and cancer.



-- Robert Preidt



SOURCE: BioMed Central, news release, June 25, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The Breast Center at Houston Northwest Medical Center Receives Prestigious National Award
2. What should a teenage girl do if she finds a lump in her breast?
3. Researchers develop new and efficient breast biopsy technique
4. St. Gallen consensus 2009: A radically different approach to treating early breast cancer
5. Breast-Feeding Boosts Childs School Performance
6. AUDIO from Medialink and Siemens: New Tool in the Battle Against Breast Cancer
7. VIDEO from Medialink and Siemens: New Treatment in Breast Cancer Detection
8. Breast Cancer TV Spot Wins Four Telly Awards
9. RNA snippet suppresses spread of aggressive breast cancer
10. Researchers identify 4 new targets for breast cancer
11. Researchers identify four new targets for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Numbers Dip Most in Wealthy, Urban Areas
(Date:8/17/2017)... ... ... Elemental LED, a leading U.S. based engineering and technology company that ... honored with Architectural SSL Product Innovation Awards (PIA) for the most innovative ... LED, provides a wide variety of superior quality linear, task, and accent LED lighting ...
(Date:8/17/2017)... ... August 17, 2017 , ... In its just released 2018 ... and Harry Nelson. This is the third consecutive year that Hardiman and Mills have ... were both recognized for expertise in Health Care Law while Mills was recognized in ...
(Date:8/17/2017)... ... August 17, 2017 , ... With the introduction of new devices, ... number of changes to the smartwatch market. As of June 2017, nearly nine percent ... the six months prior. Additionally, according to latest WEAR Report Industry Overview and Forecast ...
(Date:8/17/2017)... ... 17, 2017 , ... Momkus McCluskey Roberts LLC recently announced it ... member of the firm’s Commercial Litigation and Employment Law groups. , Ms. Parks joined ... in matters of employment litigation, commercial litigation and business disputes. Her experience includes all ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... Business Development Group, a Florida-based oncology business advisor to oncology practices, announced today ... the dollar amount of attributable savings from resolving critical clinical issues that would ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 Diplomat Pharmacy, Inc. ... Michigan residents. Naloxone ... Flint retail pharmacy, G-3320 Beecher Road. ... the Food and Drug Administration, is intended to block ... slowed breathing, and loss of consciousness. The medication is ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... --   Second-quarter 2017 revenues ... per share from continuing operations ... percent to $110 million ... $161 million Second-quarter 2017 ... increased 8 percent to $0.93 ...
Breaking Medicine Technology: